GCP
IMGO

GSA Capital Partners’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

GSA Capital Partners’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-23,835
Closed -$319K – 2000
2022
Q2 		$319K Buy
+23,835
New +$378K 0.05% 785

Other funds holding IMGO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

GSA Capital Partners's IMGO Position: Q3 2022 in Review

GSA Capital Partners sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q3 2022, closing a stake of 23,835 shares — an estimated $319K sold.

GSA Capital Partners first reported a position in IMGO in Q2 2022 and held it in 1 quarter. The position peaked at $319K in Q2 2022. 65 funds tracked by Wall St. Rank hold IMGO as of Q3 2022.

  • GSA Capital Partners reported no remaining Imago BioSciences, Inc. Common stock position as of Q3 2022 after selling out during the quarter.
  • GSA Capital Partners sold 23,835 Imago BioSciences, Inc. Common stock shares in Q3 2022, an estimated $319K.
  • GSA Capital Partners first reported a position in Imago BioSciences, Inc. Common stock in Q2 2022 and held it in 1 quarter.
  • GSA Capital Partners's Imago BioSciences, Inc. Common stock position peaked at $319K in Q2 2022.
  • 65 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q3 2022.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.